EDGAR Filing Documents for 0001193125-15-217220

Form 8-K/A - Current report: [Amend]

SEC Accession No. 0001193125-15-217220

Filing Date

2015-06-09

Accepted

2015-06-09 08:17:06

Documents

Period of Report

2015-05-08

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K/A	d939108d8ka.htm	8-K/A	41520
2	EX-3.1	d939108dex31.htm	EX-3.1	135190
3	EX-4.1	d939108dex41.htm	EX-4.1	31247
4	EX-10.1	d939108dex101.htm	EX-10.1	211844
5	EX-10.2	d939108dex102.htm	EX-10.2	48696
6	EX-10.3	d939108dex103.htm	EX-10.3	77163
7	EX-10.4	d939108dex104.htm	EX-10.4	29943
8	EX-10.5	d939108dex105.htm	EX-10.5	74249
	Complete submission text file	0001193125-15-217220.txt		651345

Mailing Address 880 WINTER STREET SUITE 210 WALTHAM MA 02451

Business Address 880 WINTER STREET SUITE 210 WALTHAM MA 02451 781-890-1199

BG Medicine, Inc. (Filer) CIK: 0001407038 (see all company filings)